Gastrointestinal OTC Drugs Market

Gastrointestinal OTC Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

2021-01-17

Published Date

Foods & Beverages

Industry

105

Pages


                    Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Gastrointestinal OTC Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market is expected to play significant role in the development of demand and improvement due to COVID-19..

Based on the type of product, the global Gastrointestinal OTC Drugs market segmented into
    Capsule
    Tablet
    Others

Based on the end-use, the global Gastrointestinal OTC Drugs market classified into
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy

Based on geography, the global Gastrointestinal OTC Drugs market segmented into
    North America [U.S., Canada, Mexico]
    Europe [Germany, UK, France, Italy, Rest of Europe]
    Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
    South America [Brazil, Argentina, Rest of Latin America]
    Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
    Bayer
    GlaxoSmithKline
    Johnson & Johnson
    Pfizer
    Perrigo
    Abbott
    C.B. Fleet
    Purdue Pharma
    Teva Pharmaceutical
    Sanofi
    Boehringer Ingelheim
    Xiuzheng Pharmaceutical Group
    China Resources Sanjiu Medical & Pharmaceutical
    Harbin Pharmaceutical Group
    JZJT
    Tongrentang (TRT)

End of Summary                  

                    Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL GASTROINTESTINAL OTC DRUGS INDUSTRY
    2.1 Summary about Gastrointestinal OTC Drugs Industry
    2.2 Gastrointestinal OTC Drugs Market Trends
        2.2.1 Gastrointestinal OTC Drugs Production & Consumption Trends
        2.2.2 Gastrointestinal OTC Drugs Demand Structure Trends
    2.3 Gastrointestinal OTC Drugs Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 Capsule
        4.2.2 Tablet
        4.2.3 Others
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Hospital Pharmacy
        4.3.2 Retail Pharmacy
        4.3.3 Online Pharmacy
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 Capsule
        5.2.2 Tablet
        5.2.3 Others
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Hospital Pharmacy
        5.3.2 Retail Pharmacy
        5.3.3 Online Pharmacy
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 Capsule
        6.2.2 Tablet
        6.2.3 Others
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Hospital Pharmacy
        6.3.2 Retail Pharmacy
        6.3.3 Online Pharmacy
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 Capsule
        7.2.2 Tablet
        7.2.3 Others
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Hospital Pharmacy
        7.3.2 Retail Pharmacy
        7.3.3 Online Pharmacy
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 Capsule
        8.2.2 Tablet
        8.2.3 Others
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Hospital Pharmacy
        8.3.2 Retail Pharmacy
        8.3.3 Online Pharmacy
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 Capsule
        9.2.2 Tablet
        9.2.3 Others
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Hospital Pharmacy
        9.3.2 Retail Pharmacy
        9.3.3 Online Pharmacy
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Bayer
        10.1.2 GlaxoSmithKline
        10.1.3 Johnson & Johnson
        10.1.4 Pfizer
        10.1.5 Perrigo
        10.1.6 Abbott
        10.1.7 C.B. Fleet
        10.1.8 Purdue Pharma
        10.1.9 Teva Pharmaceutical
        10.1.10 Sanofi
        10.1.11 Boehringer Ingelheim
        10.1.12 Xiuzheng Pharmaceutical Group
        10.1.13 China Resources Sanjiu Medical & Pharmaceutical
        10.1.14 Harbin Pharmaceutical Group
        10.1.15 JZJT
        10.1.16 Tongrentang (TRT)
    10.2  Gastrointestinal OTC Drugs Sales Date of Major Players (2017-2020e)
        10.2.1 Bayer
        10.2.2 GlaxoSmithKline
        10.2.3 Johnson & Johnson
        10.2.4 Pfizer
        10.2.5 Perrigo
        10.2.6 Abbott
        10.2.7 C.B. Fleet
        10.2.8 Purdue Pharma
        10.2.9 Teva Pharmaceutical
        10.2.10 Sanofi
        10.2.11 Boehringer Ingelheim
        10.2.12 Xiuzheng Pharmaceutical Group
        10.2.13 China Resources Sanjiu Medical & Pharmaceutical
        10.2.14 Harbin Pharmaceutical Group
        10.2.15 JZJT
        10.2.16 Tongrentang (TRT)
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT                  

List of Tables and Figures

List of Table 1.Table Gastrointestinal OTC Drugs Product Type Overview 2.Table Gastrointestinal OTC Drugs Product Type Market Share List 3.Table Gastrointestinal OTC Drugs Product Type of Major Players 4.Table Brief Introduction of Bayer 5.Table Brief Introduction of GlaxoSmithKline 6.Table Brief Introduction of Johnson & Johnson 7.Table Brief Introduction of Pfizer 8.Table Brief Introduction of Perrigo 9.Table Brief Introduction of Abbott 10.Table Brief Introduction of C.B. Fleet 11.Table Brief Introduction of Purdue Pharma 12.Table Brief Introduction of Teva Pharmaceutical 13.Table Brief Introduction of Sanofi 14.Table Brief Introduction of Boehringer Ingelheim 15.Table Brief Introduction of Xiuzheng Pharmaceutical Group 16.Table Brief Introduction of China Resources Sanjiu Medical & Pharmaceutical 17.Table Brief Introduction of Harbin Pharmaceutical Group 18.Table Brief Introduction of JZJT 19.Table Brief Introduction of Tongrentang (TRT) 20.Table Products & Services of Bayer 21.Table Products & Services of GlaxoSmithKline 22.Table Products & Services of Johnson & Johnson 23.Table Products & Services of Pfizer 24.Table Products & Services of Perrigo 25.Table Products & Services of Abbott 26.Table Products & Services of C.B. Fleet 27.Table Products & Services of Purdue Pharma 28.Table Products & Services of Teva Pharmaceutical 29.Table Products & Services of Sanofi 30.Table Products & Services of Boehringer Ingelheim 31.Table Products & Services of Xiuzheng Pharmaceutical Group 32.Table Products & Services of China Resources Sanjiu Medical & Pharmaceutical 33.Table Products & Services of Harbin Pharmaceutical Group 34.Table Products & Services of JZJT 35.Table Products & Services of Tongrentang (TRT) 36.Table Market Distribution of Major Players 37.Table Global Major Players Sales Revenue (Million USD) 2017-2020e 38.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e 39.Table Global Gastrointestinal OTC Drugs Market Forecast (Million USD) by Region 2021f-2026f 40.Table Global Gastrointestinal OTC Drugs Market Forecast (Million USD) Share by Region 2021f-2026f 41.Table Global Gastrointestinal OTC Drugs Market Forecast (Million USD) by Demand 2021f-2026f 42.Table Global Gastrointestinal OTC Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f List of Figure 1.Figure Global Gastrointestinal OTC Drugs Market Size under the Impact of COVID-19, 2017-2021f (USD Million) 2.Figure Global Gastrointestinal OTC Drugs Market by Region under the Impact of COVID-19, 2017-2021f (USD Million) 3.Figure Global Gastrointestinal OTC Drugs Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million) 4.Figure Global Gastrointestinal OTC Drugs Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million) 5.Figure Global Gastrointestinal OTC Drugs Production by Region under the Impact of COVID-19, 2021-2026 (USD Million) 6.Figure Global Gastrointestinal OTC Drugs Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million) 7.Figure Global Gastrointestinal OTC Drugs Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million) 8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 13.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 14.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 15.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 16.Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 17.Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 18.Figure Online Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 22.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 23.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 24.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 25.Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 26.Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 27.Figure Online Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 33.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 34.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 36.Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 37.Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 38.Figure Online Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 46.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 47.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 48.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 49.Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 50.Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 51.Figure Online Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 55.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 56.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 57.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 58.Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 59.Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 60.Figure Online Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 65.Figure Capsule Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 66.Figure Tablet Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 67.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 68.Figure Hospital Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 69.Figure Retail Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 70.Figure Online Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f 71.Figure Gastrointestinal OTC Drugs Sales Revenue (Million USD) of Bayer 2017-2020e 72.Figure Gastrointestinal OTC Drugs Sales Revenue (Million USD) of GlaxoSmithKline 2017-2020e 73.Figure Gastrointestinal OTC Drugs Sales Revenue (Million USD) of Johnson & Johnson 2017-2020e 74.Figure Gastrointestinal OTC Drugs Sales Revenue (Million USD) of Pfizer 2017-2020e 75.Figure Gastrointestinal OTC Drugs Sales Revenue (Million USD) of Perrigo 2017-2020e 76.Figure Gastrointestinal OTC Drugs Sales Revenue

PLEASE SELECT A FORMAT

Single User
$3000
Enterprise User
$6000
   Download Sample PDF     
Have Any Questions?

If you need a free sample copy or
have any questions regarding the
price of the reprot, reach out to us

USA & International
+1 646 583 1932
or drop us an email at
sales@readmarketresearch.com
info@readmarketresearch.com